172 related articles for article (PubMed ID: 25614169)
1. The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease.
Winthrop KL; Ku JH; Marras TK; Griffith DE; Daley CL; Olivier KN; Aksamit TR; Varley CD; Mackey K; Prevots DR
Eur Respir J; 2015 Apr; 45(4):1177-9. PubMed ID: 25614169
[No Abstract] [Full Text] [Related]
2. Prolonged use of tedizolid in a pulmonary non-tuberculous mycobacterial infection after linezolid-induced toxicity.
Yuste JR; Bertó J; Del Pozo JL; Leiva J
J Antimicrob Chemother; 2017 Feb; 72(2):625-628. PubMed ID: 27999019
[No Abstract] [Full Text] [Related]
3. Nontuberculous Mycobacterial Infections in Children.
Bhattacharya J; Mohandas S; Goldman DL
Pediatr Rev; 2019 Apr; 40(4):179-190. PubMed ID: 30936399
[No Abstract] [Full Text] [Related]
4. Safety and Effectiveness of Clofazimine for Primary and Refractory Nontuberculous Mycobacterial Infection.
Martiniano SL; Wagner BD; Levin A; Nick JA; Sagel SD; Daley CL
Chest; 2017 Oct; 152(4):800-809. PubMed ID: 28483608
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium triplex pulmonary disease with acquired macrolide resistance in immunocompetent patients.
Matsuda S; Suzuki S; Morimoto K; Aono A; Nishio K; Asakura T; Sasaki Y; Namkoong H; Nishimura T; Ogata H; Hasegawa N; Kurashima A; Ishii M; Tatsumi K; Mitarai S; Goto H
Clin Microbiol Infect; 2018 Jun; 24(6):671-672. PubMed ID: 29309938
[No Abstract] [Full Text] [Related]
6. Nontuberculous mycobacterial disease in childhood - update on diagnostic approaches and treatment.
Zimmermann P; Curtis N; Tebruegge M
J Infect; 2017 Jun; 74 Suppl 1():S136-S142. PubMed ID: 28646953
[TBL] [Abstract][Full Text] [Related]
7. New insights in the treatment of nontuberculous mycobacterial pulmonary disease.
Ruth MM; van Ingen J
Future Microbiol; 2017 Oct; 12():1109-1112. PubMed ID: 28972416
[No Abstract] [Full Text] [Related]
8. Management of nontuberculous mycobacterial (NTM) lung disease.
Philley JV; Griffith DE
Semin Respir Crit Care Med; 2013 Feb; 34(1):135-42. PubMed ID: 23460013
[TBL] [Abstract][Full Text] [Related]
9. Disseminated Mycobacterium genavense infection in an immunocompetent adult: a case report.
Cornelis G; Reynders M; Deprez J; Vankeerberghen A; Orlent H
Clin Microbiol Infect; 2018 Dec; 24(12):1355-1356. PubMed ID: 30036670
[No Abstract] [Full Text] [Related]
10. Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection.
Murray MP; Laurenson IF; Hill AT
Clin Infect Dis; 2008 Jul; 47(2):222-4. PubMed ID: 18532890
[TBL] [Abstract][Full Text] [Related]
11. [To improve diagnosis and treatment of nontuberculous mycobacterial diseases in China].
Tang SJ; Li L
Zhonghua Jie He He Hu Xi Za Zhi; 2021 Jan; 44(1):1-3. PubMed ID: 33412616
[TBL] [Abstract][Full Text] [Related]
12. Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplant.
Hirama T; Brode SK; Beswick J; Law AD; Lam W; Michelis FV; Thyagu S; Viswabandya A; Lipton JH; Messner HA; Kim DDH; Marras TK
Eur Respir J; 2018 May; 51(5):. PubMed ID: 29545280
[No Abstract] [Full Text] [Related]
13. An Unusual Rectal Mass.
Wang WL; Chang IW; Lee CT
Gastroenterology; 2018 Mar; 154(4):e10-e11. PubMed ID: 28712754
[No Abstract] [Full Text] [Related]
14. Changes in QT intervals after azithromycin-containing antibiotic therapy in patients with NTM lung disease.
Shin B; Park HY; Koh WJ
Int J Tuberc Lung Dis; 2014 Nov; 18(11):1385. PubMed ID: 25299875
[No Abstract] [Full Text] [Related]
15. Nontuberculous mycobacteria.
Chesney PJ
Pediatr Rev; 2002 Sep; 23(9):300-9. PubMed ID: 12205297
[No Abstract] [Full Text] [Related]
16. Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease.
Moon SM; Jhun BW; Daley CL; Koh WJ
Eur Respir J; 2019 May; 53(5):. PubMed ID: 30819812
[No Abstract] [Full Text] [Related]
17. Linezolid-associated optic neuropathy in a pediatric patient with Mycobacterium nonchromogenicum: A case report.
González Saldaña N; Galvis Trujillo DM; Borbolla Pertierra AM; Mondragón Pineda AI; Juárez Olguín H
Medicine (Baltimore); 2017 Dec; 96(50):e9200. PubMed ID: 29390337
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterium chlorophenolicum: An uncommon cause of peritonitis in a peritoneal dialysis patient.
Chan GCW; Mok MMY; Hung DLL; Chan JFW; Kwan LPY; Ma MKM; Yap DYH; Tang SCW
Nephrology (Carlton); 2017 Jun; 22(6):498-499. PubMed ID: 28429521
[No Abstract] [Full Text] [Related]
19. Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence.
van Ingen J; Ferro BE; Hoefsloot W; Boeree MJ; van Soolingen D
Expert Rev Anti Infect Ther; 2013 Oct; 11(10):1065-77. PubMed ID: 24124798
[TBL] [Abstract][Full Text] [Related]
20. Port-site infections by nontuberculous mycobacterium: A retrospective clinico-microbiological study.
Ghosh R; Das S; De A; Kela H; Saha ML; Maiti PK
Int J Mycobacteriol; 2017; 6(1):34-37. PubMed ID: 28317802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
